Skip to main content
. 2023 Jun 7;13(6):961. doi: 10.3390/jpm13060961

Table 3.

The prevalence of the main neurologic manifestations.

Neurologic Manifestations % pSS Patients
Central nervous system involvement 5% [137]
  Demyelinating lesions 3.6–68% * [142]
  Cranial neuropathy 16–20% * [141]
  Cognitive dysfunction 53% * [141]
Peripheral nervous system involvement 3.7–16% [138,140]
  Pure sensory neuropathy 40–49% ** [138,140]
  Sensorimotor polyneuropathies 28–56.45% ** [138,140]
Autonomic nervous system involvement 3–50% [146]

* from patients with central nervous system involvement. ** from patients with peripheral nervous system involvement.